NCT Number: NCT02039232
Safety and Efficacy of the CarboFix Pedicle Screw System
The purpose of this study is to evaluate the safety and efficacy of CarboFix' Pedicle Screw System in the lumbar spine.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Hillel Yafe MC;, Hadera, Israel
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Subject is 18 years old or older.
- Confirmation that the physical examination of radiopathy, myelopathy or combination is in correlation with the affected level.
- Lumbar CT, MRI, or myelography confirms the level of involvement is consistent with the subject's examination.
- Informed consent given by the subject.
Exclusion criteria
- Subject is not eligible for fixation with market-available fixation means.
- Familial history NF2.
- Acute traumatic spinal injury with or without neurological signs.
- Metabolic bone disease.
- History of Paget's disease or other osteodystrophies whether acquired or congenital, including renal osteodystrophy, hyperthyroidism, hypothyroidism hyperparathyroidism, Ehrlers-Danlos-syndrome, osteogenesis imperfecta, achondroplasia, tuberculosis.
- History of mental disorder or current psychiatric treatment.
- Pregnancy and/or female subjects intending to become pregnant within the expected time frame of the study and/or female subjects of child bearing age who do not use conventional contraceptive methods.
- Immune deficiency disease.
- Infection in the location of the operative site, discitis, osteomyelitis, fever and/or leukocytosis (as diagnosed based on the results of CBC and ESR tests).
- Scoliosis.
- Treatment with drugs that may interfere with bone metabolism such as:
- Cumulative dose of 150 mg. of Prednisone or equivalent within the last 6 months.
- Calcitonin within the past 6 months.
- Bisphosphonates for 30 days or more within the last 12 months.
- Bone therapeutic doses of fluoride for 30 days or more within the last 12 months.
- Bone therapeutic doses of vitamin D or Vitamin D metabolites for 30 days or more within the last 6 months.
- Treatment by chemotherapy within the last 12 months.
- Lack of willingness to make a commitment to return for required follow up visits.
- Drug and/or alcohol abuse.
- Morbid obesity.
- Metal allergies.
- Recent use of other investigational drugs or devices (within the past 30 days).
Treatment and study plan
Primary outcomes
-
Fusion success
Time frame: 6 months post-operation
Sponsors and collaborators
Lead sponsor
CarboFix Orthopedics Ltd.
Industry
Registry information
Official study title
CarboFix Pedicle Screw System
Important dates
- Study start
- 2014
- Primary completion
- 2017
- Study completion
- 2018
- First posted
- Jan 17, 2014
- Registry last updated
- Apr 17, 2019
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Quintex® Follow-up After One Year Minimum
NCT04489394
Bone Diseases, Cervical Spondylosis
Koblenz, Germany
View Trial DetailsBIO4 Clinical Case Study: Cervical Spine
NCT03077204
Bone Diseases, Congenital Abnormalities
Austin, Texas, United States
View Trial DetailsStudy of 3 Doses of NeoFuse Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion (PLF)
NCT00549913
Bone Diseases, Degenerative Disc Disease
New York, United States
View Trial DetailsAssessment of nanOss Bioactive 3D in the Posterolateral Spine
NCT01829997
Bone Diseases, Degenerative Disc Disease
New York, United States
View Trial Details